It includes structural modifications that enable GLP-1 receptor activation and a fatty acid moiety that extends its half-life to approximately five days, allowing once-weekly dosing
Standard capsules and tablets often struggle with absorption
Furthermore, the physicians order and their direct clinical supervision must be clearly evident within the medical chart
doi:10.3390/ijms16047210 76
#Healthcare #Biotech #Pharmaceuticals #Diabetes #Obesity #Innovation #ClinicalTrials To view or add a comment, sign in Anti-Obesity Drugs 1 Appetite Suppressants (Central Acting Agents) Mechanism: Reduce appetite Increase satiety Act on CNS (hypothalamus) Examples: Phentermine Phentermine + Topiramate Bupropion + Naltrexone 2 GLP-1 Receptor Agonists Mechanism: Increase insulin secretion Delay gastric emptying Promote satiety Examples: Liraglutide Semaglutide 3 Dual GIP & GLP-1 Agonist Example: Tirzepatide 4 Fat Absorption Inhibitors Mechanism: Inhibit pancreatic lipase Reduce dietary fat absorption Examples: Orlistat Cetilistat 5 Other / Adjunct Drugs Metformin (used in insulin resistance) Zonisamide (off-label) Therapeutic Effects Decrease appetite Increase fullness Reduce fat absorption Promote weight loss Improve metabolic parameters Important Note Lifestyle modification (diet + exercise) is essential along with medication
They are associated with liver and kidney dysfunction, nausea, fatigue, dizziness, rashes, weight gain, and hypoglycemia (low blood sugar)
